Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

CuraSen Therapeutics

Request full access

Curasen therapeutics, inc

San Carlos, United StatesFounded 2017Biotech & Life Sciences

About CuraSen Therapeutics

CuraSen Therapeutics, Inc. is a privately funded biopharmaceutical company focused on developing innovative treatments for neurodegenerative diseases, including Alzheimer's and Parkinson's, as well as several orphan indications. The company aims to address the growing burden of these diseases on millions of patients and their families, particularly as the population ages. CuraSen operates in the biopharmaceutical market, targeting both common and rare neurodegenerative conditions.

The business model revolves around the discovery and development of novel therapeutic compounds. CuraSen generates revenue through partnerships, licensing agreements, and potentially through the commercialization of its proprietary treatments. The company serves a diverse range of clients, including patients, healthcare providers, and pharmaceutical companies.

Founded in 2018, CuraSen leverages the expertise of its co-founders and team members, who have extensive experience in neuroscience and drug development. The company is driven by a mission to enable patients to

Source: Dealroom company data

At a glance

Status
Operational
Employees
20
Open positions
None listed
Dealroom signal
59.1/100
Industry
Health
Sub-industry
Pharmaceutical, BioTechnology
Sector
Biotechnology, Spinout, Biotech and Pharma, DT and LS, science-based
Client focus
B2B

Funding history

7 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
LATE VCOther financing Oct 2024 $46M $183M Undisclosed ↗
SERIES AOther financing Oct 2023 $18M $273M Undisclosed ↗
Showing the latest 2 of 7 recorded eventsBook a demo for the full funding history →

Growth signals

CuraSen Therapeutics website traffic

Latest recorded traffic for CuraSen Therapeutics is 2.7K monthly website visits, up 107.7% over the last three months. CuraSen Therapeutics's team grew 0% over the past year.

Latest monthly visits2.7K 3-month web change+107.7% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

CuraSen Therapeutics in the San Carlos ecosystem

Live from Dealroom

The CuraSen Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

9 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

  • Alzheimer's Drug Discovery Foundation

Series A7 investors entered at this stage

  • New Leaf Venture Partners
  • Alta Partners
  • Tekla Capital Management
  • Chiesi Ventures
  • Pappas Capital
  • Johnson & Johnson Innovation
  • Longitude Capital

Other known investors1 additional known investor

  • Stanford University
Team profiled 10 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇺🇸 United States91.7%
🇬🇧 United Kingdom8.3%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about CuraSen Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See CuraSen Therapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.